{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:42:05Z","timestamp":1788914525905,"version":"build-2803163510"},"reference-count":65,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2020,3,3]]},"DOI":"10.1080\/13543776.2020.1717470","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T08:57:15Z","timestamp":1579165035000},"page":"195-208","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":18,"title":["A literature review of the patent application publications on cabotegravir \u2013 an HIV integrase strand transfer inhibitor"],"prefix":"10.1080","volume":"30","author":[{"given":"Lidija","family":"Kova\u010d","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia"},{"name":"Analytics Department, Lek Pharmaceuticals d.d., Sandoz Development Center Slovenia, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenko","family":"\u010casar","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia"},{"name":"Analytics Department, Lek Pharmaceuticals d.d., Sandoz Development Center Slovenia, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,1,27]]},"reference":[{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1086\/648729"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu046"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.25.11456"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1126\/science.287.5453.646"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-5-114"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2010.12.008"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-018-0420-7"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2747"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1124\/mol.111.073189"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.17.3.413"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.17.1.97"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2007.43.12.1146063"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2014.050.03.2122120"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2012.658914"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1358\/dof.2012.037.010.1855759"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2012.661713"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0896-4"},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1358\/dof.2015.040.11.2383040","volume":"40","author":"Han Y","year":"2015","journal-title":"Drugs Future"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2018.1460357"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000169"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000480"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.119.258384"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000168"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2017.10.023"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2019.05.037"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.9b00451"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2019.02.009"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001343"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000161"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002690"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.2147\/HIV.S97920"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.3390\/ph12020062"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.2147\/HIV.S184642"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31917-7"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1080\/15284336.2018.1511346"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01299-18"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz439"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01695-17"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-018-0440-3"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10047-w"},{"key":"CIT0046","unstructured":"Johns BA, Kawasuji T, Taishi T, et al. inventor; Shionogi & Co., Ltd., assignee. Polycyclic carbamoylpyridone derivate having HIV integrase inhibitory activity. WO 2006\/116764 A1. 2006."},{"key":"CIT0047","unstructured":"Yoshida H, Taoda Y, Johns BA. inventor; Shionogi & Co., Ltd., GlaxoSmithKline Llc., assignee. Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates. WO 2010\/068253 A1. 2010."},{"key":"CIT0048","unstructured":"Johns BA, Duan M, Hakogi T. inventor; Shionogi & Co., Ltd., GlaxoSmithKline Llc., assignee. Process and intermediates for carbamoylpyridone HIV integrase inhibitors. WO 2010\/068262 A1. 2010."},{"key":"CIT0049","unstructured":"Wang H, Goodman SN, Mans D, et al. inventor; GlaxoSmithKline Llc., assignee. Process for preparing carbamoylpyridone derivates and intermediates. WO 2011\/119566 A1. 2011."},{"key":"CIT0050","unstructured":"Sumino Y, Okamoto K, Masui M, et al. inventor; Shionogi & Co., Ltd., assignee. Process for preparing compound having HIV integrase inhibitory activity. WO 2012\/018165 A1. 2012."},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1021\/acs.oprd.9b00031"},{"key":"CIT0052","unstructured":"Mundhra DB, Pan R. inventor; GlaxoSmithKline Llc., assignee. Pharmaceutical compositions. WO 2012\/037320 A2. 2012."},{"key":"CIT0053","unstructured":"Edagwa BJ, Gendelman HE, Johns BA. inventor; Viiv Healtcare Company, Board of regents of the University of Nebraska, assignee. Compositions and methods for the delivery of therapeutics. WO 2017\/223280 A2. 2017."},{"key":"CIT0054","unstructured":"Gendelman HE, Liu XM. inventor; The board of regents of the University of Nebraska, assignee. Compositions and methods for the delivery of therapeutics. WO 2015\/127437 A1. 2015."},{"key":"CIT0055","unstructured":"Rome L, Buehler D, Maynard HD. inventor; The regents of the University of California, assignee. Vaults engineered for hydrophobic drug delivery. WO 2015\/058025 A1. 2015."},{"key":"CIT0056","unstructured":"Karp JM, Joshi N, Rioux D, et al. inventor; The Brigham and women\u2019s hospital, Inc., assignee. Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof. WO 2018\/144991 A1. 2018."},{"key":"CIT0057","unstructured":"Grauwels H, Margolis D, Spaltenstein A, et al. inventor; Viiv HealthCare Company, Janssen Science Ireland unlimited Company, assignee. Regimens for treating HIV infections and AIDS. WO 2019\/016732 A1. 2019."},{"key":"CIT0058","unstructured":"Spreen WR., inventor; Viiv HealthCare Company, assignee. Combinations and uses treatments thereof. WO 2017\/205585 A1. 2017."},{"key":"CIT0059","unstructured":"Underwood MR., inventor; GlaxoSmithKline Llc., assignee. Antiviral therapy. WO 2011\/094150 A1. 2011."},{"key":"CIT0060","unstructured":"Scott TR. inventor; Viiv HealthCare Company, assignee. Combination drug therapy. WO 2019\/016679 A1. 2019."},{"key":"CIT0061","unstructured":"Rao DR, Malhotra G, Sawant AA, et al. inventor; Cipla Limited, assignee. Process for preparing polycyclic carbamoyl pyridone derivates and intermediates thereof. WO 2015\/177537 A1. 2015."},{"key":"CIT0062","unstructured":"Mara \u0161N, Seli \u010dL, \u010cusak A. inventor; Lek Pharmaceuticals d.d., assignee. Process for preparing dolutegravir and cabotegravir and analogues thereof. WO 2016\/113372 A1. 2016."},{"key":"CIT0063","unstructured":"Singh GP, Shrivastava D, Jadhav HS, et al. inventor; Lupin Limited, assignee. Process for the preparation of HIV integrase inhibitors. WO 2017\/109649 A1. 2017."},{"key":"CIT0064","unstructured":"Adamer V, Thaler A. inventor; Sandoz AG, assignee. Crystalline forms of cabotegravir sodium. WO 2018\/149608 A1. 2018."},{"key":"CIT0065","unstructured":"Phull MS, Thoppil SJ, Tarate SN, et al. inventor; Cipla Limited, assignee. Novel polymorphs and salts of polycyclic carbamoyl pyridone derivates. WO 2018\/109786 A1. 2018."},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005409"},{"key":"CIT0067","unstructured":"Qingfeng D, Yan Z, Tao G. inventor; YaoPharma Co. Ltd, assignee. Pharmaceutical composition for preventing and treating HIV infection. CN 109568328 A. 2019."},{"key":"CIT0068","unstructured":"Malhotra G, Joshi K, Raut P, et al. inventor; Cipla Limited, assignee. Pharmaceutical compositions comprising an anti-retroviral drug and a pharmacokinetic enhancer. WO 2017\/138022 A1. 2017."},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-041217-013717"},{"key":"CIT0070","unstructured":"Yu Z, Zhang L, Chu H, et al. inventor; Dairy cattle research center of Shandong academy of agricultural sciences, assignee. Cabotegravir. CN 109646440 A. 2019."}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2020.1717470","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T06:25:52Z","timestamp":1582179952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2020.1717470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,27]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,3]]}},"alternative-id":["10.1080\/13543776.2020.1717470"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2020.1717470","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-10-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}